Search research articles
Contact Us
Filters
Showing results (31-40 of 114) with videos related to
Page
of 12
Sort By:
Minerva Pediatrica
|
August 15, 1979
[Acrodermatitis enteropathica. Apropos of a case treated for 3 years with zinc sulfate]
G Cordone, V Venzano, C Minetti, et al.
Child'S Nervous System : Chns : Official Journal of the International Society for Pediatric Neurosurgery
|
August 1, 1996
Severe dystrophinopathy in a patient with congenital hypotonia
G Cordone, M Bado, G Morreale, et al.
La Pediatria Medica E Chirurgica : Medical and Surgical Pediatrics
|
November 1, 1984
[Critical evaluation of changes of serum CK after exertion in the identification of carriers of Duchenne's muscular dystrophy]
G Cordone, V Venzano, G Rossi, et al.
Muscle & Nerve
|
February 18, 1998
Disorganization of dystrophin costameric lattice in Becker muscular dystrophy
C Minetti, G Cordone, F Beltrame, et al.
Journal of Child Neurology
|
June 27, 2000
Novel mutation in the CPT II gene in a child with periodic febrile myalgia and myoglobinuria
C Bruno, M Bado, C Minetti, et al.
Minerva Pediatrica
|
November 15, 1986
[Congenital myopathies: possible correlations between the muscular electromyographic and histopathologic pictures. Case contribution]
C Minetti, L Doria Lamba, C Greco, et al.
The Journal of Biological Chemistry
|
August 28, 1999
Phenotypic behavior of caveolin-3 mutations that cause autosomal dominant limb girdle muscular dystrophy (LGMD-1C). Retention of LGMD-1C caveolin-3 mutants within the golgi complex
F Galbiati, D Volonte, C Minetti, et al.
Minerva Pediatrica
|
June 1, 1995
[Early myoclonic encephalopathy and spinal muscular atrophy type I]
M Bado, C Bruno, G Morreale, et al.
The Journal of Biological Chemistry
|
September 7, 2000
Limb-girdle muscular dystrophy (LGMD-1C) mutants of caveolin-3 undergo ubiquitination and proteasomal degradation. Treatment with proteasomal inhibitors blocks the dominant negative effect of LGMD-1C mutanta and rescues wild-type caveolin-3
F Galbiati, D Volonte, C Minetti, et al.
Neurology
|
February 26, 2004
Caveolinopathies: mutations in caveolin-3 cause four distinct autosomal dominant muscle diseases
S E Woodman, F Sotgia, F Galbiati, et al.
Page
of 12
Search research articles
Search
Showing results (31-40 of 114) with videos related to
Sort By:
Page
of 12
Minerva Pediatrica
|
August 15, 1979
[Acrodermatitis enteropathica. Apropos of a case treated for 3 years with zinc sulfate]
G Cordone, V Venzano, C Minetti, et al.
Child'S Nervous System : Chns : Official Journal of the International Society for Pediatric Neurosurgery
|
August 1, 1996
Severe dystrophinopathy in a patient with congenital hypotonia
G Cordone, M Bado, G Morreale, et al.
La Pediatria Medica E Chirurgica : Medical and Surgical Pediatrics
|
November 1, 1984
[Critical evaluation of changes of serum CK after exertion in the identification of carriers of Duchenne's muscular dystrophy]
G Cordone, V Venzano, G Rossi, et al.
Muscle & Nerve
|
February 18, 1998
Disorganization of dystrophin costameric lattice in Becker muscular dystrophy
C Minetti, G Cordone, F Beltrame, et al.
Journal of Child Neurology
|
June 27, 2000
Novel mutation in the CPT II gene in a child with periodic febrile myalgia and myoglobinuria
C Bruno, M Bado, C Minetti, et al.
Minerva Pediatrica
|
November 15, 1986
[Congenital myopathies: possible correlations between the muscular electromyographic and histopathologic pictures. Case contribution]
C Minetti, L Doria Lamba, C Greco, et al.
The Journal of Biological Chemistry
|
August 28, 1999
Phenotypic behavior of caveolin-3 mutations that cause autosomal dominant limb girdle muscular dystrophy (LGMD-1C). Retention of LGMD-1C caveolin-3 mutants within the golgi complex
F Galbiati, D Volonte, C Minetti, et al.
Minerva Pediatrica
|
June 1, 1995
[Early myoclonic encephalopathy and spinal muscular atrophy type I]
M Bado, C Bruno, G Morreale, et al.
The Journal of Biological Chemistry
|
September 7, 2000
Limb-girdle muscular dystrophy (LGMD-1C) mutants of caveolin-3 undergo ubiquitination and proteasomal degradation. Treatment with proteasomal inhibitors blocks the dominant negative effect of LGMD-1C mutanta and rescues wild-type caveolin-3
F Galbiati, D Volonte, C Minetti, et al.
Neurology
|
February 26, 2004
Caveolinopathies: mutations in caveolin-3 cause four distinct autosomal dominant muscle diseases
S E Woodman, F Sotgia, F Galbiati, et al.
Page
of 12